BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34338150)

  • 1. Prognostic marker identification based on weighted gene co-expression network analysis and associated
    Guo H; Yang J; Liu S; Qin T; Zhao Q; Hou X; Ren L
    Bioengineered; 2021 Dec; 12(1):4666-4680. PubMed ID: 34338150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
    Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
    PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatic analysis of hub markers and immune cell infiltration characteristics of gastric cancer.
    Li C; Yang T; Yuan Y; Wen R; Yu H
    Front Immunol; 2023; 14():1202529. PubMed ID: 37359529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
    Li D; Yin Y; He M; Wang J
    Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of GNG7 as a novel biomarker and potential therapeutic target for gastric cancer via bioinformatic analysis and
    Duan H; Chen B; Wang W; Luo H
    Aging (Albany NY); 2023 Feb; 15(5):1445-1474. PubMed ID: 36863706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Develop a circular RNA-related regulatory network associated with prognosis of gastric cancer.
    Wei S; Teng S; Yao J; Gao W; Zang J; Wang G; Hu Z
    Cancer Med; 2020 Nov; 9(22):8589-8599. PubMed ID: 32902196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing.
    Zhao X; Wu S; Jing J
    Pathol Oncol Res; 2021; 27():1609955. PubMed ID: 34899080
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of early diagnostic biomarkers via WGCNA in gastric cancer.
    Rezaei Z; Ranjbaran J; Safarpour H; Nomiri S; Salmani F; Chamani E; Larki P; Brunetti O; Silvestris N; Tavakoli T
    Biomed Pharmacother; 2022 Jan; 145():112477. PubMed ID: 34864309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Diagnostic and Prognostic Differentially Expressed Genes of Gastric Cancer Based on Bioinformatics Analyses of RNA-seq Data.
    Wang M; Jiang X; Xu S; Deng Y; Cao T; Cheng Y; Zhang WH; Zhang L; Hu J
    Genet Test Mol Biomarkers; 2022 Nov; 26(11):512-521. PubMed ID: 36383109
    [No Abstract]   [Full Text] [Related]  

  • 12. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
    Zhang X; Jiang Y; Xie Y; Leng X; Song F
    DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis.
    Ma Z; Xu J; Ru L; Zhu W
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33754626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of SCN7A as the key gene associated with tumor mutation burden in gastric cancer.
    Li W; Zhou K; Li M; Hu Q; Wei W; Liu L; Zhao Q
    BMC Gastroenterol; 2022 Feb; 22(1):45. PubMed ID: 35123417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer.
    Zhao Q; Xie J; Xie J; Zhao R; Song C; Wang H; Rong J; Yan L; Song Y; Wang F; Xie Y
    Cancer Biomark; 2021; 31(1):59-75. PubMed ID: 33780362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 17. ACAN, MDFI, and CHST1 as Candidate Genes in Gastric Cancer: A Comprehensive Insilco Analysis.
    Vafaeie F; Nomiri S; Ranjbaran J; Safarpour H
    Asian Pac J Cancer Prev; 2022 Feb; 23(2):683-694. PubMed ID: 35225482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.
    Sun T; Wang D; Ping Y; Sang Y; Dai Y; Wang Y; Liu Z; Duan X; Tao Z; Liu W
    Int J Oncol; 2020 Feb; 56(2):460-469. PubMed ID: 31894266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of gastric cancer-associated gene signatures: Evidence based on a meta-analysis using integrated bioinformatics methods.
    Wang J; Gao P; Song Y; Sun J; Chen X; Yu H; Wang Y; Wang Z
    J Cell Mol Med; 2018 Nov; 22(11):5743-5747. PubMed ID: 30133128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis identifies oxidative stress genes associated with progression and prognosis in gastric cancer.
    Wu Z; Wang L; Wen Z; Yao J
    Sci Rep; 2021 Feb; 11(1):3292. PubMed ID: 33558567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.